All Stories

  1. Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma

    Article • BioMed Research International, January 2018, Hindawi Publishing Corporation

    Maria Teresa Busceti, Eugenio Garofalo, Corrado Pelaia

  2. Severe eosinophilic asthma: from the pathogenic role of interleukin-5 to the therapeutic action of mepolizumab

    Article • Drug Design Development and Therapy, October 2017, Dove Medical Press

    Maria Teresa Busceti, Dr Luca Gallelli, Corrado Pelaia

  3. Role of biologics in severe eosinophilic asthma – focus on reslizumab

    Article • Therapeutics and Clinical Risk Management, July 2016, Dove Medical Press

    Dr Luca Gallelli, Maria Teresa Busceti

  4. Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD

    Article • Therapeutics and Clinical Risk Management, October 2015, Dove Medical Press

    Dr Luca Gallelli, Maria Teresa Busceti, Cecilia Calabrese